ITCI

Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook

01/22 09:21 am

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSE - ENFN), Intra-Cellular Therapies, Inc. (Nasdaq - ITCI), H&E Equipment Services, Inc. (Nasdaq - HEES), Shutterstock, Inc. (NYSE - SSTK)

01/21 09:03 am

MicroStrategy, SoFi Technologies And Carvana Are Among Top Large-Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

01/19 09:33 am

$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – CCNE, ITCI, ENFN, AMPY

01/16 07:15 pm

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders

01/13 10:20 pm

Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal

01/13 11:03 am

Intra-Cellular Therapies Announces Presentations at the 2024 Psych Congress and NEI Congress

11/07 09:00 am

Intra-Cellular Therapies to Host Third Quarter 2024 Financial Results Conference Call and Webcast

10/17 08:00 am

Intra-Cellular Therapies Announces Presentations at the 2024 European College of Neuropsychopharmacology Congress

09/23 08:00 am

Intra-Cellular Therapies to Present at the Canaccord Genuity 44th Annual Growth Conference

08/08 08:00 am

Intra-Cellular's (ITCI) Caplyta Boosts Sales, Dependence a Woe

06/24 09:52 am

Biotech Stock Roundup: ITCI Up on Study Data, ZNTL, OVID Down on Updates & More News

06/20 11:39 am

Intra-Cellular (ITCI) Up as Second Depression Study Meets Goals

06/19 10:27 am

Intra-Cellular (ITCI) Soars 9.6%: Is Further Upside Left in the Stock?

06/19 06:27 am

Intra-Cellular Therapies Announces Positive Topline Results in Second Phase 3 Trial Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

06/18 07:30 am

Where Intra-Cellular Therapies Stands With Analysts

06/12 10:01 am

Intra-Cellular Therapies to Present at the 45th Annual Goldman Sachs Global Healthcare Conference

06/10 08:00 am

Why Is Intra-Cellular (ITCI) Up 1.2% Since Last Earnings Report?

06/06 11:31 am

Intra-Cellular Therapies to Present at the Jefferies Global Healthcare Conference

05/29 08:00 am

Analyst Ratings For Intra-Cellular Therapies

05/08 04:00 pm

Intra-Cellular (ITCI) Q1 Earnings and Sales Beat Estimates

05/08 11:43 am

Intra-Cellular Therapies (ITCI) Reports Q1 Loss, Tops Revenue Estimates

05/07 08:40 am

Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast

04/30 08:00 am

Will Intra-Cellular Therapies (ITCI) Report Negative Q1 Earnings? What You Should Know

04/25 10:01 am

Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

04/24 04:01 pm

The Analyst Verdict: Intra-Cellular Therapies In The Eyes Of 14 Experts

04/22 09:00 am

Biotech Stock Roundup: REGN, SAGE, NMRA Down on Updates, ITCI Gains on Study Success

04/18 01:55 pm

Intra-Cellular Therapies Prices Public Offering of Common Stock

04/17 08:46 pm

Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals

04/17 09:21 am

Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?

04/17 07:36 am

Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday

04/17 02:06 am

Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

04/16 04:06 pm

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

04/16 02:17 pm

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

04/16 10:15 am

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder

04/16 07:00 am

8 Analysts Assess Intra-Cellular Therapies: What You Need To Know

04/03 10:01 am

Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

03/19 08:30 am

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

03/06 09:00 am

Intra-Cellular Therapies to Present at the 44th Annual TD Cowen Health Care Conference

02/27 09:00 am

Intra-Cellular (ITCI) Q4 Loss Narrower Than Expected, Sales Miss

02/23 09:41 am

Where Intra-Cellular Therapies Stands With Analysts

02/23 08:00 am

Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update

02/22 08:30 am

Biotech/Drug Stocks Q4 Earnings Due Feb 22: MRNA, BHC, NTLA, BMRN & More

02/21 10:13 am

Fate Therapeutics (FATE) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

02/19 11:00 am

Ultragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates

02/15 06:10 pm

Intra-Cellular Therapies (ITCI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

02/15 11:00 am

Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?

02/15 07:20 am

Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?

02/14 07:20 am

Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast

02/08 09:00 am

Analyst Scoreboard: 8 Ratings For Intra-Cellular Therapies

01/18 10:00 am